You're reading everything related to:

Medical cannabis

Key Insights From The Pharmaceutical Cannabis Report

Key Insights From CBD: The Consumer Report

CBD: The Consumer Report is the latest release in the suite of Prohibition Partners’ market-leading consumer research reports, providing proprietary data on over 15,000 adults from seven key global markets,...

Synthetic cannabinoid firm’s stock tanks 77% after failed clinical trials

Corbus Pharmaceuticals, one of the leaders in the pharmaceutical cannabinoid industry takes a hit as their lead drug fails in advanced clinical trials.

Australian medical cannabis approvals rising despite COVID-19 disruptions

After a quarter of stalled growth, approvals for cannabis-based medicines via the SAS-B route is now accelerating once more.

Europe is recording one million cannabis offences a year

Drug offences involving cannabis are following a stable, albeit slightly rising trend in Europe, which registers over one million cannabis offences each year, despite the fact that over 25 million...

Product testing in Australia reveals inconsistencies over cannabinoid potency

Last Friday, Australian regulator TGA published test results on the most common medical cannabis products sold in Australia. Results, which showed 23% of products had cannabinoid levels which differed from...

Prohibition Partners LIVE returns this November with global cannabis conference

Cannabis market set to offer welcome relief during global recession

European Cannabis: Waking The Sleeping Giant

The consolidation of fully legalised and regulated cannabis industries in North America has powered hope that the same progressive systems might be implemented as quickly and successfully elsewhere. However, the...

Prohibition Partners Interviews Pharmin’s CEO Ana Kobalia

Pharmin is a vertically integrated Uruguayan company, formed in June 2019 as a result of a transnational partnership of experienced and successful entrepreneurs. Today, the company is proud of its...

Germany: Insured medicinal cannabis sales worth €75 million in the first half of 2020

New data just released from the National Association of Statutory Health Insurance Funds (GKV) shows continued year on year growth of the German medicinal cannabis market, despite signs that growth...

Recreational cannabis projects beginning to emerge in Europe

Prohibitionist ideologies embedded in the international narcotic treaties have hampered the development of legal recreational cannabis programmes in Europe. However, we have seen the emergence of cannabis social clubs and...

Prohibition Partners interviews cannabinoid expert D'Arcy Bond from Newell Sciences

Newell Sciences is a fully integrated cannabinoid producer that delivers high quality cannabinoids to the global market. Prohibition Partners sits down with D’Arcy Bond, Director of Newell Sciences, to discuss...

US Congressional Committee Approves the Medical Cannabis Research Act

Key insights from THE IMPACT SERIES: Disrupting Food

Israeli cannabis patient numbers reach 60,000 as imports are on course to dominate domestic market

Cannabis patient numbers in Israel have reached a record high in 2020, breaking the 60,000 mark. However, compliance issues for local producers have hamstrung the domestic market with imports rising...

Medical cannabis patient numbers reach 20,000 in Brazil

Individual patient authorisations to import cannabis products into Brazil continue to surge, as shown by the most recent data provided by Brazilian health regulator ANVISA to Prohibition Partners.

Medical growers planning over 300 tonnes of European-grown cannabis

For the majority of the previous two decades, the Netherlands was responsible for the sole commercial cultivation of cannabis in Europe. Now, half a dozen European states produce cannabis for...

Clarification: Is Cannabis a Cure for COVID?

Currently, over 22 million people have been infected with COVID-19 worldwide and researchers estimate that it will take months before we have medicines that effectively treat or cure the virus...

European medical cannabis trade: Southern Europe becoming largest supplier

The rising demand for medical cannabis in Europe, driven primarily by maturing markets such as Germany, Italy and the Netherlands, has opened the door to new sources for medical cannabis...

Hemp farming in the US: total acreage shrinks for the first time

Is the age of exponential growth in hemp farming coming to an end? If so, what does this mean for the supply-demand balance of the CBD industry? With CBD gradually...

Over 30% of adults in Europe and North America willing to try infused beverages

Proprietary consumer surveys from Prohibition Partners show that a significant proportion of the adult populations in Europe’s major cannabis markets and North America are willing to try infused beverages.

July records largest single-month patient growth in Australia as authorisations surge

Earlier today, the TGA of Australia released data on medical cannabis authorisations for July, showing the largest single month increase in prescription approvals to date.

Social Listening: Positive sentiment dominant ahead of New Zealand referendum

Recent online sentiment analysis has suggested cannabis legislation is now being viewed favourably by citizens in New Zealand.

Argentina announces plans to broaden medical cannabis schemes

Argentina has drafted regulations to increase accessibility to medicinal cannabis in 2020, allowing more patients to get access.

Germany imports 4,126kg of medical cannabis during the first half of 2020

Yesterday, Germany’s BfArM released new data on medical cannabis imports from Q1 and Q2 2020, showing an increase of 16% in Q1 2020 and 32% in Q2 2020.

Canadian legal cannabis sales set to surpass CAD$2 billion in 2020 and outpace illegal production

According to StatsCan, Canadian retailers sold a record CAD$185.9 million worth of cannabis in May 2020.

FDA set to launch widespread CBD testing plan to tackle product inconsistencies

Earlier this month, the US FDA released data on the US CBD market as part of a review by the White House relating to cannabis and CBD research.

UK CBD market facing shake up as prices drop and premium CPG brands set to emerge

Over the last two years, the UK CBD market has enjoyed low barriers to entry, a lack of regulatory standards and extremely high premiums for inconsistent high street products.

Deputy Ministers submit proposal to legalise adult-use cannabis in Guernsey

Two Deputy Ministers have submitted proposals to fully legalise recreational cannabis, with the hope of implementing an operating model similar to the one used in Canada.

Medical Cannabis Prescriptions Grow 400% year-on-year in the Czech Republic

Czech Republic passes 1,000 monthly patients mark as flower prescriptions grow 400% year-on-year

Overcapacity continues to loom over the Canadian market despite players slashing costs

Despite increasing demand, both in the medical and adult-use markets, inventory figures continued to increase in tandem, leading to an oversupply in the Canadian market.

Cannabis 2.0 boosts legal cannabis sales in Canada

Health Canada has resumed the publication of monthly data on the Canadian market, showing a steady increase in medical cannabis sales since October 2019.

Key Insights from The Impact Series: Disrupting Drinks

Disrupting Drinks is the latest report in The Impact Series — Prohibition Partners’ suite of in-depth reports detailing the impact of cannabis across key consumer markets — and the first...

Israeli cannabis market heats up as elections approach

“The cannabis industry is at a unique turning point, turning within a dramatically short time-frame from a pariah to a main-stage industry. Some 35 countries have already legalised cannabis to...

ECH, Grow and IPS create historic milestone

ECH, Grow Biotech and IPS Specials have created a historic milestone by importing the first bulk shipment of cannabis-based medicine to the UK, since the Home Office legalised medical cannabis...

UK medicinal cannabis use hampered by lack of doctor training

The European Cannabis Report™ 4th Edition is the most extensive review to date of the European cannabis industry. It examines legislation, regulation, market size and market opportunities in 33 European...

Cannabis Europa to unlock French medical cannabis industry

Following a string of key developments in 2018, France has begun reviewing their existing conservative cannabis policy by establishing a committee to review the legal status of the medical cannabis...

UK medical cannabis is now legal, but what can we expect?

Medical cannabis is officially available in the UK today via prescription and millions of patients, who suffer from registered conditions that can be treated with cannabis, could qualify for treatment.

European presence expanded in Spanish cannabis capital

Prohibition Partners is delighted to launch its first overseas office in Barcelona, Spain. The office is run by Head of Consulting David Attwood, who recently joined the team and will...

Cannabis Patient boom in Germany puts pressure on supply

Since March 2017, medical cannabis has been legal in Germany, launching a new domestic industry, and attracting the watchful eye of the global cannabis community. Previously, the state had only...

Dutch cannabis sector to take control back from the black market

Dutch cannabis laws are not without fault. Since the introduction of coffee shops in 1976, Amsterdam’s cannabis has been supplied by criminal organisations. Additionally, a lack of cannabis cultivation licences,...

Government giving mixed signals on medical Romania cannabis legislation

Romania’s history has been full of rebounds, ebbs and flows of distress and productivity, often playing catch up to rejoin the socio-economic norms of mainstream Europe. Once a powerful hemp...

Serbian patients fight for cannabis reform

Serbia is the largest and most populous country of the former Yugoslavia. It is home to a strong pro-legalisation movement which is led by activists, patients and researchers. In this...

The Israel cannabis sector, a global leader

Israel has been a pioneer in the research and development of medical cannabis for decades. THC and the endocannabinoid system were first discovered there.

Ireland cannabis legalisation hits roadblock in pursuit of medical classification

A Bill calling for the legalisation of medical cannabis in Ireland was rejected by the Oireachtas Health Committee in July over fears that it could potentially “decriminalise the recreational use...

Poland passes bill to legalise medical cannabis

Poland’s lower house of parliament (Sejm) has voted overwhelmingly in favour of making medical cannabis legal “under certain circumstances”.

Greece legalises cannabis for medical use

On June 30th, the Greek Prime Minister, Alexis Tsipras and Health Minister, Andreas Xanthos announced that Greece is to become the seventh European country to legalise cannabis for medical use.

German Cannabis leads the European medical market

January 19th, 2017 saw a major development in Germany’s relationship with cannabis. German parliament unanimously voted to make it legal for doctors to prescribe cannabis-based treatments for ‘seriously ill’ patients.

news

intelligence

insights

on the cannabis market

Our weekly newsletter brings you the most important developments, news and informed commentary on the global cannabis industry.